Skip to content

Discovery Programs

R&D Pipeline

Gubra has a robust R&D pipeline focused on target discovery and peptide drug development. We specialize in metabolic, fibrotic, and inflammatory diseases, where we have deep scientific expertise.

Why Gubra?
  • Innovative, data-driven approach
  • Expert guidance in targets and disease areas
  • High-quality data with integrity, speed, and flexibility
  • Professional and agile project organization
Drug discovery

Consult with Louise S. Dalbøge

Chief Science Officer

Choose the right, trustworthy discovery partner.

Balanced portfolio of internal & partnered programs

Gubra’s R&D Pipeline

Gubra’s R&D pipeline features a balanced mix of partnered programs and internal projects, available for partnering now or at a later stage. Contact us to learn more.

Our scientific expertise, combined with AI-driven platforms, is the foundation of our strong pipeline.


We combine AI and machine learning with cutting-edge science to accelerate our programs. Our agile approach, coupled with complete in-house capabilities, ensures speed and high-quality data.
Niels Vrang (co-founder)
muusfoto_IMG01327-scaled

Key figures

5

Active Partnerships
  • Current collaboration partners: Boehringer Ingelheim and Hemab.
  • A long-term trusted alliance partner

4

Clinical Development
  • Four projects in clinical development phase
  • Two projects in Phase I

6+

Open Projects
  • A diverse portfolio of internal projects
  • Ready to be partnered now or later

Related pages

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top